CJC-1295 With DAC 5mg

Description

CJC-1295 With DAC 5mg For Sale — Long-Acting GHRH Research Peptide

CJC-1295 with DAC (Drug Affinity Complex) is a modified Growth Hormone-Releasing Hormone (GHRH) analogue engineered for extended plasma half-life. The DAC modification enables CJC-1295 to bind albumin in the bloodstream, extending its active window from hours to approximately 6–8 days per injection — making it the longest-acting GHRH analogue available for research.

Research Profile

Research on CJC-1295 with DAC has documented sustained, dose-dependent elevations in GH and IGF-1 levels following single administrations. This extended activity profile differentiates it significantly from CJC-1295 without DAC, which produces short GH pulses. Researchers studying chronic GH secretagogue effects, body composition changes over extended protocols, and comparisons between pulsatile vs sustained GH release patterns use the DAC form as a key research tool. The 5mg vial supports longer-duration research protocols.

Product Specifications

• Compound: CJC-1295 with DAC (Modified GHRH analogue)
• Amount: 5mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Testing: Third-party Certificate of Analysis available
• Storage: -20°C lyophilized; 4°C after reconstitution, use within 28 days
• For laboratory and research use only — not for human consumption

For research and laboratory use only. Not intended for human consumption.